What impact can fluorine-18 fluorodeoxyglucose ET/computed tomography have on HIV/AIDS nd tuberculosis pandemic?

Nuclear Medicine Communications

Volumn 30, Issue 4, 2009, Pages 255-257

  Sathekge, Mike ^a   Maes, Alex ^b   A Nahhas, Adil ^c   Rubello, Domenico ^d   Chiti, Arturo ^e  

^a STEVE BIKO ACADEMIC HOSPITAL   (South Africa)

^b AZ GROENINGE   (Belgium)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d S MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^e HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR; FLUORODEOXYGLUCOSE F 18; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4+ T LYMPHOCYTE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; EDITORIAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIXED INFECTION; PANDEMIC; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE DIAGNOSIS; TUBERCULOSIS; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DISEASE OUTBREAKS; FLUORODEOXYGLUCOSE F18; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TUBERCULOSIS, PULMONARY;

EID: 63149111447     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3283163b92     Document Type: Editorial

References (21)

1. + T lymphocytes in HIV-infected patients treated with interleukin-2. AIDS 1999; 13:455-463.
2. Haramati LB, Jenny-Avital ER, Merman D. Thoracic Manifestations of Immune Restoration Syndromes in AIDS. J Thoracic Imag 2007; 22: 213-220.
3. Cohen PT, Sande M, Volberding P. Clinical spectrum of HIV disease. In: The AIDS knowledge base: a textbook of HIV. Boston: Little Brown; 1994.
4. Horsburg CR. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324:1332-1338.
5. Lacombe C, Lewin M, Monnier-Chollet L, Pacanowski J, Poirot JL, Arrive L, Tubiana JM. Imaging of thoracic pathology in patients with AIDS. J Radiol 2007;88:1145-1154.
6. Liu RS, Shei HR, Chu YK, Feng CF, Su WJ. Detection of extrapulmonary tuberculosis with F-18 FDG PET. Rev Med Nucl Alasbinm J 2002; 17:504.
7. Cinque P, Scarpellini P, Vago L, Linde A, Lazzarin A. Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. Aids 1997; 11:1-17.
8. Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. Aids 1999; 13:1249-1253.
9. Nath A, Sacktor N. Influence of highly active antiretroviral therapy on persistence of HIV in the central nervous system. Curr Opin Neurol 2006; 19:358-361.
10. Banati BB. Visualising microglial activation in vivo. Glia 2002; 40:206-217.
11. Cagnin A, Gerhard A, Banati RB. In vivo imaging of neuroinflammation. Eur Neuropsychopharmacol 2002; 12:581-586.
12. Gupta NC, Frank AR, Dewan NA. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992; 184:441-444.
13. Malik K, Dedhia HV, Bishop H. Clinical utility of PET-FDG imaging in detecting malignancy in pulmonary lesions. Chest 1996; 110 (Suppl):95S.
14. Goo JM, Im J-G, Do K-H. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology 2000; 216:117-121.
15. Gambhir SS, Czernin J, Schwimmer J. A tabulated summary of the FDG PET literature. J Nucl Med 2001; 42:1 S-93S.
16. Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 1994; 35:1647-1649.
17. Miceli M, Atoui R, Walker R. Diagnosis of deep septic thrombophlebitis in cancer patients by fluorine-18 fluorodeoxyglucose positron emission tomography scanning: a preliminary report. J Clin Oncol 2004; 22: 1949-1956.
18. Radin R. HIV infection: analysis in 259 consecutive patients with abnormal abdominal CT findings. Radiology 1995; 197:712-722.
19. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 3rd ed. Geneva: World Health Organization; 2003.
20. Ichiya Y, Kuwabara Y, Sasaki M. FDG-PET in infectious lesions: the detection and assessment of lesion activity. Ann Nucl Med 1996; 10: 185-191.
21. Schmitz A, Kalicke T, Willkomm P. Use of fluorine-18 Fluoro-2-deoxy-D- glucose positron emission tomography in assessing the process of tuberculoous spondylitis. J Spinal Discord 2000; 13:541-544.